Csaba Polgár

ORCID: 0000-0001-7245-0762
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Advanced Radiotherapy Techniques
  • Breast Lesions and Carcinomas
  • Breast Implant and Reconstruction
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Cancer Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • BRCA gene mutations in cancer
  • Global Cancer Incidence and Screening
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Treatment and Pharmacology
  • Cancer Genomics and Diagnostics
  • Effects of Radiation Exposure
  • Lung Cancer Diagnosis and Treatment
  • Advances in Oncology and Radiotherapy
  • Medical Imaging Techniques and Applications
  • Multiple and Secondary Primary Cancers
  • Endometrial and Cervical Cancer Treatments
  • Salivary Gland Tumors Diagnosis and Treatment
  • Radiation Dose and Imaging
  • Brain Metastases and Treatment
  • Management of metastatic bone disease
  • Radiation Therapy and Dosimetry
  • Sarcoma Diagnosis and Treatment

National Institute of Oncology
2016-2025

Semmelweis University
2017-2025

Országos Reumatológiai és Fizioterápiás Intézet
2015-2025

Országos Pszichiátriai és Neurológiai Intézet
2004-2024

Advanced Radiation Therapy (United States)
2023-2024

Gynecologic Oncology Group
2012-2024

NYU Langone Health
2023-2024

Stellar Science (United States)
2023-2024

Spanish Oncology Genitourinary Group
2012-2024

Memorial Sloan Kettering Cancer Center
2012-2023

To report the long-term results of a single-institution randomized study comparing breast-conserving treatment with partial breast irradiation (PBI) or conventional whole (WBI).Between 1998 and 2004, 258 selected women pT1 pN0-1mi M0, grade 1-2, non-lobular cancer without presence extensive intraductal component resected negative margins were after BCS to receive 50 Gy WBI (n=130) PBI (n=128). The latter consisted either 7 × 5.2 high-dose-rate (HDR) multi-catheter brachytherapy (BT; n=88)...

10.1016/j.radonc.2013.05.008 article EN cc-by-nc-nd Radiotherapy and Oncology 2013-06-03

Abstract Background and Objectives The objectives of this study were to test the feasibility sole interstitial high‐dose‐rate brachytherapy (HDR‐BT) after breast‐conserving surgery (BCS) for T1 breast cancer in a phase I–II study, present initial findings III trial comparing efficacy tumor bed radiotherapy (TBRT) alone with conventional whole (WBRT). Methods Forty‐five prospectively selected patients undergoing BCS enrolled into TBRT alone, using HDR implants. HDR‐BT 7 × 4.33 Gy (n = 8) 5.2...

10.1002/jso.10110 article EN Journal of Surgical Oncology 2002-06-20

Documenting the distribution of radiotherapy departments and availability equipment in European countries is an important part HERO - ESTRO Health Economics Radiation Oncology project. has overall aim to develop a knowledge base provision Europe build model for health economic evaluation radiation treatments at level. The current report describe countries.An 84-item questionnaire was sent out countries, principally through their national societies. includes detailed analysis (questionnaire...

10.1016/j.radonc.2014.08.029 article EN cc-by-nc-nd Radiotherapy and Oncology 2014-08-01

BackgroundThe ESTRO Health Economics in Radiation Oncology (HERO) project has the overall aim to develop a knowledge base of provision radiotherapy Europe and build model for health economic evaluation radiation treatments at European level. The first milestone was assess availability resources within Europe. This paper presents personnel data collected HERO database.Materials methodsAn 84-item questionnaire sent out countries, through their national scientific professional societies....

10.1016/j.radonc.2014.08.034 article EN cc-by-nc-nd Radiotherapy and Oncology 2014-08-01
Coming Soon ...